+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Biopharmaceutical Analytical Testing Services Market 2023-2027

  • PDF Icon

    Report

  • 171 Pages
  • January 2023
  • Region: Global
  • TechNavio
  • ID: 4894365
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The biopharmaceutical analytical testing services market is forecasted to grow by $3449.57 mn during 2022-2027, accelerating at a CAGR of 12.61% during the forecast period. The report on the biopharmaceutical analytical testing services market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increase in demand for mAbs, an increase in the number of patent-expired drugs, and an increase in chronic diseases.

The biopharmaceutical analytical testing services market is segmented as below:

By Service

  • Bioanalytical
  • Method development and validation
  • Stability testing
  • Others

By End-user

  • Pharma
  • biotech companies
  • CROs

By Geographical Landscape

  • North America
  • APAC
  • Europe
  • South America
  • Middle East and Africa
This study identifies the rise in investment in r and d as one of the prime reasons driving the biopharmaceutical analytical testing services market growth during the next few years. Also, the rise in the production of vaccines and increasing outsourcing of analytical testing services will lead to sizable demand in the market.

The report on the biopharmaceutical analytical testing services market covers the following areas:

  • Biopharmaceutical analytical testing services market sizing
  • Biopharmaceutical analytical testing services market forecast
  • Biopharmaceutical analytical testing services market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading biopharmaceutical analytical testing services market vendors that include Almac Group Ltd., Boston Analytical, Catalent Inc., Charles River Laboratories International Inc., Coriolis Pharma Research GmbH, Curia Inc., Element Materials Technology Group Ltd., Eurofins Scientific SE, ICON plc, Intertek Group Plc, Laboratory Corp. of America Holdings, Merck KGaA, Pace Analytical Services LLC, Parexel International Corp., SGS SA, Solvias AG, STERIS Plc, Thermo Fisher Scientific Inc., Vimta Labs Ltd., and West Pharmaceutical Services Inc. Also, the biopharmaceutical analytical testing services market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Service
Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size
4.1 Global biopharmaceutical analytical testing services market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on Global biopharmaceutical analytical testing services market 2017 - 2021 ($ million)
4.2 Service Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Service Segment 2017 - 2021 ($ million)
4.3 End-user Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Service
6.1 Market segments
Exhibit 30: Chart on Service - Market share 2022-2027 (%)
Exhibit 31: Data Table on Service - Market share 2022-2027 (%)
6.2 Comparison by Service
Exhibit 32: Chart on Comparison by Service
Exhibit 33: Data Table on Comparison by Service
6.3 Bioanalytical - Market size and forecast 2022-2027
Exhibit 34: Chart on Bioanalytical - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Bioanalytical - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Bioanalytical - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Bioanalytical - Year-over-year growth 2022-2027 (%)
6.4 Method development and validation - Market size and forecast 2022-2027
Exhibit 38: Chart on Method development and validation - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Method development and validation - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Method development and validation - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Method development and validation - Year-over-year growth 2022-2027 (%)
6.5 Stability testing - Market size and forecast 2022-2027
Exhibit 42: Chart on Stability testing - Market size and forecast 2022-2027 ($ million)
Exhibit 43: Data Table on Stability testing - Market size and forecast 2022-2027 ($ million)
Exhibit 44: Chart on Stability testing - Year-over-year growth 2022-2027 (%)
Exhibit 45: Data Table on Stability testing - Year-over-year growth 2022-2027 (%)
6.6 Others - Market size and forecast 2022-2027
Exhibit 46: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 47: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 48: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 49: Data Table on Others - Year-over-year growth 2022-2027 (%)
6.7 Market opportunity by Service
Exhibit 50: Market opportunity by Service ($ million)

7 Market Segmentation by End-user
7.1 Market segments
Exhibit 51: Chart on End-user - Market share 2022-2027 (%)
Exhibit 52: Data Table on End-user - Market share 2022-2027 (%)
7.2 Comparison by End-user
Exhibit 53: Chart on Comparison by End-user
Exhibit 54: Data Table on Comparison by End-user
7.3 Pharma and biotech companies - Market size and forecast 2022-2027
Exhibit 55: Chart on Pharma and biotech companies - Market size and forecast 2022-2027 ($ million)
Exhibit 56: Data Table on Pharma and biotech companies - Market size and forecast 2022-2027 ($ million)
Exhibit 57: Chart on Pharma and biotech companies - Year-over-year growth 2022-2027 (%)
Exhibit 58: Data Table on Pharma and biotech companies - Year-over-year growth 2022-2027 (%)
7.4 CROs - Market size and forecast 2022-2027
Exhibit 59: Chart on CROs - Market size and forecast 2022-2027 ($ million)
Exhibit 60: Data Table on CROs - Market size and forecast 2022-2027 ($ million)
Exhibit 61: Chart on CROs - Year-over-year growth 2022-2027 (%)
Exhibit 62: Data Table on CROs - Year-over-year growth 2022-2027 (%)
7.5 Market opportunity by End-user
Exhibit 63: Market opportunity by End-user ($ million)

8 Customer Landscape
8.1 Customer landscape overview
Exhibit 64: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 65: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 66: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 67: Chart on Geographic comparison
Exhibit 68: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 69: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 70: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 71: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 72: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 APAC - Market size and forecast 2022-2027
Exhibit 73: Chart on APAC - Market size and forecast 2022-2027 ($ million)
Exhibit 74: Data Table on APAC - Market size and forecast 2022-2027 ($ million)
Exhibit 75: Chart on APAC - Year-over-year growth 2022-2027 (%)
Exhibit 76: Data Table on APAC - Year-over-year growth 2022-2027 (%)
9.5 Europe - Market size and forecast 2022-2027
Exhibit 77: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 78: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 79: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 80: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.6 South America - Market size and forecast 2022-2027
Exhibit 81: Chart on South America - Market size and forecast 2022-2027 ($ million)
Exhibit 82: Data Table on South America - Market size and forecast 2022-2027 ($ million)
Exhibit 83: Chart on South America - Year-over-year growth 2022-2027 (%)
Exhibit 84: Data Table on South America - Year-over-year growth 2022-2027 (%)
9.7 Middle East and Africa - Market size and forecast 2022-2027
Exhibit 85: Chart on Middle East and Africa - Market size and forecast 2022-2027 ($ million)
Exhibit 86: Data Table on Middle East and Africa - Market size and forecast 2022-2027 ($ million)
Exhibit 87: Chart on Middle East and Africa - Year-over-year growth 2022-2027 (%)
Exhibit 88: Data Table on Middle East and Africa - Year-over-year growth 2022-2027 (%)
9.8 US - Market size and forecast 2022-2027
Exhibit 89: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 90: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 91: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 92: Data Table on US - Year-over-year growth 2022-2027 (%)
9.9 China - Market size and forecast 2022-2027
Exhibit 93: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 94: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 95: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 96: Data Table on China - Year-over-year growth 2022-2027 (%)
9.10 Japan - Market size and forecast 2022-2027
Exhibit 97: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 98: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 99: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibit 100: Data Table on Japan - Year-over-year growth 2022-2027 (%)
9.11 UK - Market size and forecast 2022-2027
Exhibit 101: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 102: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 103: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 104: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.12 Germany - Market size and forecast 2022-2027
Exhibit 105: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 106: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 107: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 108: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.13 Market opportunity By Geographical Landscape
Exhibit 109: Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 110: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 111: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 112: Overview on factors of disruption
11.4 Industry risks
Exhibit 113: Impact of key risks on business

12 Vendor Analysis
12.1 Vendors covered
Exhibit 114: Vendors covered
12.2 Market positioning of vendors
Exhibit 115: Matrix on vendor position and classification
12.3 Almac Group Ltd.
Exhibit 116: Almac Group Ltd. - Overview
Exhibit 117: Almac Group Ltd. - Product / Service
Exhibit 118: Almac Group Ltd. - Key offerings
12.4 Boston Analytical
Exhibit 119: Boston Analytical - Overview
Exhibit 120: Boston Analytical - Product / Service
Exhibit 121: Boston Analytical - Key news
Exhibit 122: Boston Analytical - Key offerings
12.5 Catalent Inc.
Exhibit 123: Catalent Inc. - Overview
Exhibit 124: Catalent Inc. - Business segments
Exhibit 125: Catalent Inc. - Key news
Exhibit 126: Catalent Inc. - Key offerings
Exhibit 127: Catalent Inc. - Segment focus
12.6 Charles River Laboratories International Inc.
Exhibit 128: Charles River Laboratories International Inc. - Overview
Exhibit 129: Charles River Laboratories International Inc. - Business segments
Exhibit 130: Charles River Laboratories International Inc. - Key news
Exhibit 131: Charles River Laboratories International Inc. - Key offerings
Exhibit 132: Charles River Laboratories International Inc. - Segment focus
12.7 Coriolis Pharma Research GmbH
Exhibit 133: Coriolis Pharma Research GmbH - Overview
Exhibit 134: Coriolis Pharma Research GmbH - Product / Service
Exhibit 135: Coriolis Pharma Research GmbH - Key offerings
12.8 Element Materials Technology Group Ltd.
Exhibit 136: Element Materials Technology Group Ltd. - Overview
Exhibit 137: Element Materials Technology Group Ltd. - Product / Service
Exhibit 138: Element Materials Technology Group Ltd. - Key offerings
12.9 Eurofins Scientific SE
Exhibit 139: Eurofins Scientific SE - Overview
Exhibit 140: Eurofins Scientific SE - Business segments
Exhibit 141: Eurofins Scientific SE - Key news
Exhibit 142: Eurofins Scientific SE - Key offerings
Exhibit 143: Eurofins Scientific SE - Segment focus
12.10 ICON plc
Exhibit 144: ICON plc - Overview
Exhibit 145: ICON plc - Product / Service
Exhibit 146: ICON plc - Key offerings
12.11 Intertek Group Plc
Exhibit 147: Intertek Group Plc - Overview
Exhibit 148: Intertek Group Plc - Business segments
Exhibit 149: Intertek Group Plc - Key news
Exhibit 150: Intertek Group Plc - Key offerings
Exhibit 151: Intertek Group Plc - Segment focus
12.12 Merck KGaA
Exhibit 152: Merck KGaA - Overview
Exhibit 153: Merck KGaA - Business segments
Exhibit 154: Merck KGaA - Key news
Exhibit 155: Merck KGaA - Key offerings
Exhibit 156: Merck KGaA - Segment focus
12.13 Pace Analytical Services LLC
Exhibit 157: Pace Analytical Services LLC - Overview
Exhibit 158: Pace Analytical Services LLC - Product / Service
Exhibit 159: Pace Analytical Services LLC - Key offerings
12.14 SGS SA
Exhibit 160: SGS SA - Overview
Exhibit 161: SGS SA - Business segments
Exhibit 162: SGS SA - Key offerings
Exhibit 163: SGS SA - Segment focus
12.15 Solvias AG
Exhibit 164: Solvias AG - Overview
Exhibit 165: Solvias AG - Product / Service
Exhibit 166: Solvias AG - Key news
Exhibit 167: Solvias AG - Key offerings
12.16 STERIS Plc
Exhibit 168: STERIS Plc - Overview
Exhibit 169: STERIS Plc - Business segments
Exhibit 170: STERIS Plc - Key news
Exhibit 171: STERIS Plc - Key offerings
Exhibit 172: STERIS Plc - Segment focus
12.17 West Pharmaceutical Services Inc.
Exhibit 173: West Pharmaceutical Services Inc. - Overview
Exhibit 174: West Pharmaceutical Services Inc. - Business segments
Exhibit 175: West Pharmaceutical Services Inc. - Key news
Exhibit 176: West Pharmaceutical Services Inc. - Key offerings
Exhibit 177: West Pharmaceutical Services Inc. - Segment focus

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 178: Inclusions checklist
Exhibit 179: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 180: Currency conversion rates for US$
13.4 Research methodology
Exhibit 181: Research methodology
Exhibit 182: Validation techniques employed for market sizing
Exhibit 183: Information sources
13.5 List of abbreviations
Exhibit 184: List of abbreviations

List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Service
Exhibits 6: Executive Summary - Chart on Market Segmentation by End-user
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Vendor Market Positioning
Exhibits 10: Parent market
Exhibits 11: Market Characteristics
Exhibits 12: Offerings of vendors included in the market definition
Exhibits 13: Market segments
Exhibits 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 18: Historic Market Size - Data Table on Global biopharmaceutical analytical testing services market 2017 - 2021 ($ million)
Exhibits 19: Historic Market Size - Service Segment 2017 - 2021 ($ million)
Exhibits 20: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
Exhibits 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits 23: Five forces analysis - Comparison between 2022 and 2027
Exhibits 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits 26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits 27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits 28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits 29: Chart on Market condition - Five forces 2022 and 2027
Exhibits 30: Chart on Service - Market share 2022-2027 (%)
Exhibits 31: Data Table on Service - Market share 2022-2027 (%)
Exhibits 32: Chart on Comparison by Service
Exhibits 33: Data Table on Comparison by Service
Exhibits 34: Chart on Bioanalytical - Market size and forecast 2022-2027 ($ million)
Exhibits 35: Data Table on Bioanalytical - Market size and forecast 2022-2027 ($ million)
Exhibits 36: Chart on Bioanalytical - Year-over-year growth 2022-2027 (%)
Exhibits 37: Data Table on Bioanalytical - Year-over-year growth 2022-2027 (%)
Exhibits 38: Chart on Method development and validation - Market size and forecast 2022-2027 ($ million)
Exhibits 39: Data Table on Method development and validation - Market size and forecast 2022-2027 ($ million)
Exhibits 40: Chart on Method development and validation - Year-over-year growth 2022-2027 (%)
Exhibits 41: Data Table on Method development and validation - Year-over-year growth 2022-2027 (%)
Exhibits 42: Chart on Stability testing - Market size and forecast 2022-2027 ($ million)
Exhibits 43: Data Table on Stability testing - Market size and forecast 2022-2027 ($ million)
Exhibits 44: Chart on Stability testing - Year-over-year growth 2022-2027 (%)
Exhibits 45: Data Table on Stability testing - Year-over-year growth 2022-2027 (%)
Exhibits 46: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibits 47: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibits 48: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits 49: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits 50: Market opportunity by Service ($ million)
Exhibits 51: Chart on End-user - Market share 2022-2027 (%)
Exhibits 52: Data Table on End-user - Market share 2022-2027 (%)
Exhibits 53: Chart on Comparison by End-user
Exhibits 54: Data Table on Comparison by End-user
Exhibits 55: Chart on Pharma and biotech companies - Market size and forecast 2022-2027 ($ million)
Exhibits 56: Data Table on Pharma and biotech companies - Market size and forecast 2022-2027 ($ million)
Exhibits 57: Chart on Pharma and biotech companies - Year-over-year growth 2022-2027 (%)
Exhibits 58: Data Table on Pharma and biotech companies - Year-over-year growth 2022-2027 (%)
Exhibits 59: Chart on CROs - Market size and forecast 2022-2027 ($ million)
Exhibits 60: Data Table on CROs - Market size and forecast 2022-2027 ($ million)
Exhibits 61: Chart on CROs - Year-over-year growth 2022-2027 (%)
Exhibits 62: Data Table on CROs - Year-over-year growth 2022-2027 (%)
Exhibits 63: Market opportunity by End-user ($ million)
Exhibits 64: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 65: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits 66: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits 67: Chart on Geographic comparison
Exhibits 68: Data Table on Geographic comparison
Exhibits 69: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits 70: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits 71: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits 72: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits 73: Chart on APAC - Market size and forecast 2022-2027 ($ million)
Exhibits 74: Data Table on APAC - Market size and forecast 2022-2027 ($ million)
Exhibits 75: Chart on APAC - Year-over-year growth 2022-2027 (%)
Exhibits 76: Data Table on APAC - Year-over-year growth 2022-2027 (%)
Exhibits 77: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits 78: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits 79: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 80: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 81: Chart on South America - Market size and forecast 2022-2027 ($ million)
Exhibits 82: Data Table on South America - Market size and forecast 2022-2027 ($ million)
Exhibits 83: Chart on South America - Year-over-year growth 2022-2027 (%)
Exhibits 84: Data Table on South America - Year-over-year growth 2022-2027 (%)
Exhibits 85: Chart on Middle East and Africa - Market size and forecast 2022-2027 ($ million)
Exhibits 86: Data Table on Middle East and Africa - Market size and forecast 2022-2027 ($ million)
Exhibits 87: Chart on Middle East and Africa - Year-over-year growth 2022-2027 (%)
Exhibits 88: Data Table on Middle East and Africa - Year-over-year growth 2022-2027 (%)
Exhibits 89: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits 90: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits 91: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits 92: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits 93: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits 94: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits 95: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits 96: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits 97: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits 98: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits 99: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibits 100: Data Table on Japan - Year-over-year growth 2022-2027 (%)
Exhibits 101: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits 102: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits 103: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits 104: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits 105: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits 106: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits 107: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 108: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 109: Market opportunity By Geographical Landscape ($ million)
Exhibits 110: Impact of drivers and challenges in 2022 and 2027
Exhibits 111: Overview on Criticality of inputs and Factors of differentiation
Exhibits 112: Overview on factors of disruption
Exhibits 113: Impact of key risks on business
Exhibits 114: Vendors covered
Exhibits 115: Matrix on vendor position and classification
Exhibits 116: Almac Group Ltd. - Overview
Exhibits 117: Almac Group Ltd. - Product / Service
Exhibits 118: Almac Group Ltd. - Key offerings
Exhibits 119: Boston Analytical - Overview
Exhibits 120: Boston Analytical - Product / Service
Exhibits 121: Boston Analytical - Key news
Exhibits 122: Boston Analytical - Key offerings
Exhibits 123: Catalent Inc. - Overview
Exhibits 124: Catalent Inc. - Business segments
Exhibits 125: Catalent Inc. - Key news
Exhibits 126: Catalent Inc. - Key offerings
Exhibits 127: Catalent Inc. - Segment focus
Exhibits 128: Charles River Laboratories International Inc. - Overview
Exhibits 129: Charles River Laboratories International Inc. - Business segments
Exhibits 130: Charles River Laboratories International Inc. - Key news
Exhibits 131: Charles River Laboratories International Inc. - Key offerings
Exhibits 132: Charles River Laboratories International Inc. - Segment focus
Exhibits 133: Coriolis Pharma Research GmbH - Overview
Exhibits 134: Coriolis Pharma Research GmbH - Product / Service
Exhibits 135: Coriolis Pharma Research GmbH - Key offerings
Exhibits 136: Element Materials Technology Group Ltd. - Overview
Exhibits 137: Element Materials Technology Group Ltd. - Product / Service
Exhibits 138: Element Materials Technology Group Ltd. - Key offerings
Exhibits 139: Eurofins Scientific SE - Overview
Exhibits 140: Eurofins Scientific SE - Business segments
Exhibits 141: Eurofins Scientific SE - Key news
Exhibits 142: Eurofins Scientific SE - Key offerings
Exhibits 143: Eurofins Scientific SE - Segment focus
Exhibits 144: ICON plc - Overview
Exhibits 145: ICON plc - Product / Service
Exhibits 146: ICON plc - Key offerings
Exhibits 147: Intertek Group Plc - Overview
Exhibits 148: Intertek Group Plc - Business segments
Exhibits 149: Intertek Group Plc - Key news
Exhibits 150: Intertek Group Plc - Key offerings
Exhibits 151: Intertek Group Plc - Segment focus
Exhibits 152: Merck KGaA - Overview
Exhibits 153: Merck KGaA - Business segments
Exhibits 154: Merck KGaA - Key news
Exhibits 155: Merck KGaA - Key offerings
Exhibits 156: Merck KGaA - Segment focus
Exhibits 157: Pace Analytical Services LLC - Overview
Exhibits 158: Pace Analytical Services LLC - Product / Service
Exhibits 159: Pace Analytical Services LLC - Key offerings
Exhibits 160: SGS SA - Overview
Exhibits 161: SGS SA - Business segments
Exhibits 162: SGS SA - Key offerings
Exhibits 163: SGS SA - Segment focus
Exhibits 164: Solvias AG - Overview
Exhibits 165: Solvias AG - Product / Service
Exhibits 166: Solvias AG - Key news
Exhibits 167: Solvias AG - Key offerings
Exhibits 168: STERIS Plc - Overview
Exhibits 169: STERIS Plc - Business segments
Exhibits 170: STERIS Plc - Key news
Exhibits 171: STERIS Plc - Key offerings
Exhibits 172: STERIS Plc - Segment focus
Exhibits 173: West Pharmaceutical Services Inc. - Overview
Exhibits 174: West Pharmaceutical Services Inc. - Business segments
Exhibits 175: West Pharmaceutical Services Inc. - Key news
Exhibits 176: West Pharmaceutical Services Inc. - Key offerings
Exhibits 177: West Pharmaceutical Services Inc. - Segment focus
Exhibits 178: Inclusions checklist
Exhibits 179: Exclusions checklist
Exhibits 180: Currency conversion rates for US$
Exhibits 181: Research methodology
Exhibits 182: Validation techniques employed for market sizing
Exhibits 183: Information sources
Exhibits 184: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global biopharmaceutical analytical testing services market: Almac Group Ltd., Boston Analytical, Catalent Inc., Charles River Laboratories International Inc., Coriolis Pharma Research GmbH, Curia Inc., Element Materials Technology Group Ltd., Eurofins Scientific SE, ICON plc, Intertek Group Plc, Laboratory Corp. of America Holdings, Merck KGaA, Pace Analytical Services LLC, Parexel International Corp., SGS SA, Solvias AG, STERIS Plc, Thermo Fisher Scientific Inc., Vimta Labs Ltd., and West Pharmaceutical Services Inc.

Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is the rise in investment in R&D.`

According to the report, one of the major drivers for this market is the increase in demand for mAbs.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Almac Group Ltd.
  • Boston Analytical
  • Catalent Inc.
  • Charles River Laboratories International Inc.
  • Coriolis Pharma Research GmbH
  • Curia Inc.
  • Element Materials Technology Group Ltd.
  • Eurofins Scientific SE
  • ICON plc
  • Intertek Group Plc
  • Laboratory Corp. of America Holdings
  • Merck KGaA
  • Pace Analytical Services LLC
  • Parexel International Corp.
  • SGS SA
  • Solvias AG
  • STERIS Plc
  • Thermo Fisher Scientific Inc.
  • Vimta Labs Ltd.
  • West Pharmaceutical Services Inc.